Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors

Cancer Research

Volumn 59, Issue 9, 1999, Pages 2223-2228

  Hong, Sung H ^a   Avis, Ingalill ^a   Michele D, Vos ^a   Martínez, Alfredo ^a   Treston, Anthony M ^a   Mulshine, James L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; ARACHIDONATE LIPOXYGENASE; ARACHIDONIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ENZYME INHIBITOR; MESSENGER RNA; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; EPITHELIUM TUMOR; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ARACHIDONATE 12-LIPOXYGENASE; ARACHIDONATE 5-LIPOXYGENASE; ARACHIDONIC ACID; BREAST NEOPLASMS; CARCINOMA; CARRIER PROTEINS; CELL DIVISION; COLONIC NEOPLASMS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME INDUCTION; EPITHELIAL CELLS; FEMALE; GROWTH INHIBITORS; HUMANS; ISOENZYMES; LIPOXYGENASE INHIBITORS; LUNG NEOPLASMS; MALE; MEMBRANE PROTEINS; NEOPLASM PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTATIC NEOPLASMS; RNA, MESSENGER; RNA, NEOPLASM; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0033135492     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Marnett, L. J., and Honn, K. V. Overview of articles on eiosanoids and cancer. Cancer Metastasis Rev., 13: 237-239, 1994.
2. Marnett, L. J. Generation of mutagens during arachidonic acid metabolism. Cancer Metastasis Rev., 13: 303-308, 1994.
3. Earashi, M., Noguchi, M., Kinoshita, K., and Tanaka, M. Effects of eicosanoid synthesis inhibitors on the in vitro growth and prostaglandin E and leukotriene B secretion of a human breast cancer cell line. Oncology, 52: 150-155, 1995.
4. Noguchi, M., Earashi, M., Minami, M., Miyazaki, I., Tanaka, M., and Sasaki, T. Effects of piroxicam and esculetin on the MDA-MB-231 human breast cancer cell line. Prostaglandins Leukotrienes Essent. Fatty Acids, 53: 325-329, 1995.
5. Ghosh, J., and Myers, C. E. Arachidonic acid stimulates prostate cancer cell growth: critical role of 5-lipoxygenase. Biochem. Biophys. Res. Commun., 235: 418-423, 1997.
6. Avis, I. M., Jett, M., Boyle, T., Vos, M. D., Moody, T., Treston, A. M., Martinez, A., and Mulshine, J. L. Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling. J. Clin. Invest., 97: 806-813, 1996.
7. Liu, B., Maher, R. J., Hannun, Y. A., Porter, A. T., and Honn, K. V. 12(S)-HETE enhancement of prostate tumor cell invasion: selective role of PKC α. J. Natl. Cancer Inst., 86: 1145-1151, 1994.
8. Hussey, T. J., and Tisdale, M. J. Inhibition of tumor growth by lipoxygenase inhibitors. Br. J. Cancer, 74: 683-687, 1996.
9. Reddy, B. S., Rao, C. V., and Seibert, K. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res., 56: 4566-4569, 1996.
10. Tang, D. G., Chen, Y. Q., and Honn, K. V. Arachidonate lipoxygenase as essential regulators of cell survival and apoptosis. Proc. Natl. Acad. Sci. USA, 93: 5241-5246, 1996.
11. Lupulescu, A. Prostaglandins, their inhibitors and cancer. Prostaglandins Leukotrienes Essent. Fatty Acids, 54: 83-94, 1996.
12. Sheng, H., Shao, J., Kirkland, S. C., Isakson, P., Coffey, R. J., Morrow, J., Beauchamp, R. D, and DuBois, R. N. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J. Clin. Invest., 99: 2254-2259, 1997.
13. Avis, I., Hong, S. H., Moody, T., and Mulshine, J. L. In vitro and in vivo correlation between inhibition of the lipoxygenase (LO) pathway and up-regulation of apoptosis in breast cancer cell lines. Proc. Am. Assoc. Cancer Res., 39: 115, 1998.
14. Phelps, R. M., Johnson, B. E., Ihde, D. C., Gazdar, A. F., Linnoila, R. I., Carney, D., Minna, J. D., and Mulshine, J. L. NCI-Navy Medical Oncology Branch cell line data base. J. Cell. Biochem. Suppl., 24: 32-91, 1996.
15. Riendeau, D., Falgueyret, J. P., Nathaniel, D. J., Rokach, J., Ueda, N., and Yamamoto, S. Sensitivity of immunoaffmity-purified porcine 5-lipoxygenase to inhibitors and activating lipid hydroperoxides. Biochem. Pharmacol., 38: 2313-2321, 1989.
16. Dixon, R. A., Diehl, R. E., Opas, E., Rands, E., Vickers, P. J., Evans, J. F., Gillard, J. W., and Miller, D. K. Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis. Nature (Lond.), 343: 282-284, 1990.
17. Sekiya, K., and Okuda, H. Selective inhibition of platelet lipoxygenase by baicalcm. Biochem. Biophys. Res. Commun., 105: 1090-1095, 1982.
18. Cho, H., Ueda, M., Tamaoka, M., Hamaguchi, M., Aisaka, K., Kiso, Y., Inoue, T., Ogino, R., Tatsuoka, T., Ishihara, T., Noguchi, T., Morita, I., and Murota, S. Novel caffeic acid derivatives: extremely potent inhibitors of 12-lipoxygenase. J. Med. Chem., 34: 1503-1505, 1991.
19. Salari, H., Braquet, P., and Borgeat, P. Comparative effects of indomethacin, acetylenic acids, 15-HETE, nordihydroguaiaretic acid and BW755C on the metabolism of arachidonic acid in human leukocytes and platelets. Prostaglandins Leukotrienes Med., 13: 53-60, 1984.
20. Bokoch, G. M., and Reed, P. W. Evidence for inhibition of leukotriene A4 synthesis by 5,8,11,14-eicosatetraynoic acid in guinea pig polymorphonuclear leukocytes. J. Biol. Chem., 256: 4156-4159, 1981.
21. Shen, T. Y., and Winter, C. A. Chemical and biological studies on indomethacin, sulindac and their analogs. Adv. Drug Res., 12: 90-245, 1977.
22. Futaki, N., Takahashi, S., Yokoyama, M., Arai, I., Higuchi, S., and Otomo, S. NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins, 47: 55-59, 1994.
23. Nakanishi, Y., Cuttitta, F., Kasprzyk, P. G., Avis, I., Steinberg, S. M., Gazdar, A. F., and Mulshine, J. L. Growth factor effects on small cell lung cancer using a colorimetric assay: can a transferrin-like growth factor mediate autocrine growth? Exp. Cell Biol., 56: 74-85, 1988.
24. Liu, X. H., and, Rose, D. P. Differential expression and regulation of cyclooxygenase-1 and -2 in two human breast cancer cell lines. Cancer Res., 56: 5125-5127, 1996.
25. Di Marzo, V. Arachidonic acid and eicosanoids as targets and effectors in second messenger interactions. Prostaglandins Leukotrienes Essent. Fatty Acids, 53: 239-254, 1995.
26. Reich, R., and Martin, G. R. Identification of arachidonic acid pathways required for the invasive and metastatic activity of malignant tumor cells. Prostaglandins, 5/: 1-17, 1996.
27. Yamamoto, S. Mammalian lipoxygenases: molecular structures and functions. Biochira. Biophys. Acta, 1128: 117-131, 1992.
28. Izumi, T., Hoshiko, S., Radmark, O., and Samuelsson, B. Cloning of the cDNA for human 12-lipoxygenase. Proc. Natl. Acad. Sci. USA, 87: 7477-7481, 1990.
29. Chang, W. C., Liu, Y. W., Ning, C. C., Suzuki, H., Yoshimoto, T., and Yamamoto, S. Induction of arachidonate 12-lipoxygenase mRNA by epidermal growth factor in A431 cells. J. Biol. Chem., 268: 18734-18739, 1993.
30. Conrad, D. J., Kuhn, H., Mulkins, M., Highland, E., and Sigal, E. Specific inflammatory cytokines regulate the expression of human monocyte 15-lipoxygenase. Proc. Natl. Acad. Sci. USA, 89: 217-221, 1992.
31. Williams, C. S., and DuBois, R. N. Prostaglandin endoperoxide synthase: why two isoforms? Am. J. Physiol, 270: G393-G400, 1996.
32. Wilson, D. E., DiGianfilippo, A., Ondrey, F. G., Anderson, K. M., and Harris, J. E. Effect of nordihydroguaiaretic acid on cultured rat and human glioma cell proliferation. J. Neurosurg., 71: 551-557, 1989.
33. McCormick, D. L., and Spicer, A. M. Nordihydroguaiaretic acid suppression of rat mammary carcinogenesis induced by N-methyl-N-nitrosourea. Cancer Lett., 37: 139-146, 1987.
34. Ford-Hutchinson, A. W., Gresser, M., and Young, R. N. 5-Lipoxygenase. Annu. Rev. Biochem., 63: 383-417, 1994.
35. Potter, M. Experimental plasmacytomagenesis in mice. Hematol. Oncol. Clin. North Am., 11: 323-345, 1997.
36. Goodwin, J. S., and Ceuppens, J. Regulation of immune response by prostaglandins. J. Clin. Immunol., 3: 295-315, 1983.